MAIA

Bullish

MAIA Biotechnology Announces Open Market Purchases by CEO and Director

MAIA Biotechnology's CEO, Vlad Vitoc, M.D., and Director, Stan V. Smith, Ph.D., significantly increased their ownership stakes through open market pur...

The Manila Times 59 mins ago 0

Bullish

Cancer-drug CEO, director buy MAIA stock at $1.3877 and $1.336

MAIA Biotechnology's founder and CEO, Vlad Vitoc, and Director Stan V. Smith, have made open market purchases of MAIA common stock, acquiring approxim...

Stock Titan 52 mins ago 0